ibandronic acid has been researched along with Diabetes Mellitus, Type 2 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baek, KH; Kang, MI; Kim, J; Kim, KM; Lim, S; Min, YK | 1 |
| Bao, X; Gao, L; Li, Y; Liu, C; Tian, Y; Wang, K | 1 |
1 trial(s) available for ibandronic acid and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Efficacy of bisphosphonate therapy on postmenopausal osteoporotic women with and without diabetes: a prospective trial.
Topics: Bone Density; Bone Density Conservation Agents; Diabetes Mellitus, Type 2; Diphosphonates; Female; Humans; Ibandronic Acid; Osteoporosis, Postmenopausal; Prospective Studies; Treatment Outcome | 2022 |
1 other study(ies) available for ibandronic acid and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Denosumab Improves Glycaemic Parameters in Postmenopausal Osteoporosis Patients with Combined Type 2 Diabetes Mellitus.
Topics: Denosumab; Diabetes Mellitus, Type 2; Female; Glucagon-Like Peptide 1; Glucose; Humans; Ibandronic Acid; Osteoporosis, Postmenopausal; Transcription Factors | 2023 |